Interaction of macrophage antigen 1 and CD40 ligand leads to IL-12 production and resistance in CD40-deficient mice infected with Leishmania major

Journal of Immunology

Volumn 195, Issue 7, 2015, Pages 3218-3226

  Okwor, Ifeoma ^a   Jia, Ping ^b   Uzonna, Jude E ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 12; IL12A PROTEIN, MOUSE; INTERLEUKIN 12P35; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; DRUG EFFECT; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFECTION RESISTANCE; INFECTION SENSITIVITY; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SKIN DEFECT; TH1 CELL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL MOTION; CYTOLOGY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LEISHMANIA MAJOR; LYMPH NODE; PARASITOLOGY; PATHOLOGY; RECURRENT DISEASE; SKIN LEISHMANIASIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; CD40 LIGAND; CELL MOVEMENT; DENDRITIC CELLS; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MACROPHAGE-1 ANTIGEN; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECOMBINANT PROTEINS; RECURRENCE; TH1 CELLS;

EID: 84942474195     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500922     Document Type: Article

References (46)

1. Croft, M., W. Duan, H. Choi, S. Y. Eun, S. Madireddi, and A. Mehta. 2012. TNF superfamily in inflammatory disease: translating basic insights. Trends Immunol. 33: 144-152.
2. Marovich, M. A., M. A. McDowell, E. K. Thomas, and T. B. Nutman. 2000. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. J. Immunol. 164: 5858-5865.
3. Ferlin, W. G., T. von der Weid, F. Cottrez, D. A. Ferrick, R. L. Coffman, and M. C. Howard. 1998. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb. Eur. J. Immunol. 28: 525-531.
4. Heinzel, F. P., R. M. Rerko, and A. M. Hujer. 1998. Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity. Cell. Immunol. 184: 129-142.
5. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4: 283-289.
6. Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4: 275-281.
7. Soong, L., J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley, Jr., N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4: 263-273.
8. Padigel, U. M., and J. P. Farrell. 2003. CD40-CD40 ligand costimulation is not required for initiation and maintenance of a Th1-type response to Leishmania major infection. Infect. Immun. 71: 1389-1395.
9. Padigel, U. M., P. J. Perrin, and J. P. Farrell. 2001. The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation. J. Immunol. 167: 5874-5879.
10. Zirlik, A., C. Maier, N. Gerdes, L. MacFarlane, J. Soosairajah, U. Bavendiek, I. Ahrens, S. Ernst, N. Bassler, A. Missiou, et al. 2007. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 115: 1571-1580.
11. Ross, G. D. 2002. Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion. Immunol. Res. 25: 219-227.
12. Polando, R., U. G. Dixit, C. R. Carter, B. Jones, J. P. Whitcomb, W. Ballhorn, M. Harintho, C. L. Jerde, M. E. Wilson, and M. A. McDowell. 2013. The roles of complement receptor 3 and Fcg receptors during Leishmania phagosome maturation. J. Leukoc. Biol. 93: 921-932.
13. Domínguez, M., and A. Toraño. 1999. Immune adherence-mediated opsonophagocytosis: the mechanism of Leishmania infection. J. Exp. Med. 189: 25-35.
14. Velasco-Velázquez, M. A., D. Barrera, A. González-Arenas, C. Rosales, and J. Agramonte-Hevia. 2003. Macrophage-Mycobacterium tuberculosis interactions: role of complement receptor 3. Microb. Pathog. 35: 125-131.
15. Tan, S. M. 2012. The leucocyte b2 (CD18) integrins: the structure, functional regulation and signalling properties. Biosci. Rep. 32: 241-269.
16. Uzonna, J. E., K. L. Joyce, and P. Scott. 2004. Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. J. Exp. Med. 199: 1559-1566.
17. Liu, D., T. Zhang, A. J. Marshall, K. Okkenhaug, B. Vanhaesebroeck, and J. E. Uzonna. 2009. The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J. Immunol. 183: 1921-1933.
18. Mou, Z., D. Liu, I. Okwor, P. Jia, K. Orihara, and J. E. Uzonna. 2014. MHC class II restricted innate-like double negative T cells contribute to optimal primary and secondary immunity to Leishmania major. PLoS Pathog. 10: e1004396.
19. Park, A. Y., B. D. Hondowicz, and P. Scott. 2000. IL-12 is required to maintain a Th1 response during Leishmania major infection. J. Immunol. 165: 896-902.
20. Park, A. Y., and P. Scott. 2001. Il-12: keeping cell-mediated immunity alive. Scand. J. Immunol. 53: 529-532.
21. Hondowicz, B. D., A. Y. Park, M. M. Elloso, and P. Scott. 2000. Maintenance of IL-12-responsive CD4+ T cells during a Th2 response in Leishmania majorinfected mice. Eur. J. Immunol. 30: 2007-2014.
22. Gorak, P. M., C. R. Engwerda, and P. M. Kaye. 1998. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur. J. Immunol. 28: 687-695.
23. Wolf, D., J. D. Hohmann, A. Wiedemann, K. Bledzka, H. Blankenbach, T. Marchini, K. Gutte, K. Zeschky, N. Bassler, N. Hoppe, et al. 2011. Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis-but does not affect immunity and thrombosis in mice. Circ. Res. 109: 1269-1279.
24. Schönbeck, U., and P. Libby. 2001. The CD40/CD154 receptor/ligand dyad. Cell. Mol. Life Sci. 58: 4-43.
25. Shu, U., M. Kiniwa, C. Y. Wu, C. Maliszewski, N. Vezzio, J. Hakimi, M. Gately, and G. Delespesse. 1995. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25: 1125-1128.
26. Kennedy, M. K., K. S. Picha, W. C. Fanslow, K. H. Grabstein, M. R. Alderson, K. N. Clifford, W. A. Chin, and K. M. Mohler. 1996. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol. 26: 370-378.
27. Padigel, U. M., N. Kim, Y. Choi, and J. P. Farrell. 2003. TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice. J. Immunol. 171: 5437-5441.
28. Xu, G., D. Liu, I. Okwor, Y. Wang, H. Korner, S. K. Kung, Y. X. Fu, and J. E. Uzonna. 2007. LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major. J. Immunol. 179: 6901-6909.
29. Okwor, I., G. Xu, H. Tang, Y. Liang, Y. X. Fu, and J. E. Uzonna. 2015. Deficiency of CD40 Reveals an Important Role for LIGHT in Anti-Leishmania Immunity. J. Immunol. 195: 194-202.
30. Léveillé, C., M. Bouillon, W. Guo, J. Bolduc, E. Sharif-Askari, Y. El-Fakhry, C. Reyes-Moreno, R. Lapointe, Y. Merhi, J. A. Wilkins, and W. Mourad. 2007. CD40 ligand binds to alpha5beta1 integrin and triggers cell signaling. J. Biol. Chem. 282: 5143-5151.
31. Loeser, R. F. 1993. Integrin-mediated attachment of articular chondrocytes to extracellular matrix proteins. Arthritis Rheum. 36: 1103-1110.
32. Loeser, R. F. 2014. Integrins and chondrocyte-matrix interactions in articular cartilage. Matrix Biol. 39: 11-16.
33. Ricardo-Carter, C., M. Favila, R. E. Polando, R. N. Cotton, K. Bogard Horner, D. Condon, W. Ballhorn, J. P. Whitcomb, M. Yadav, R. L. Geister, et al. 2013. Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription. Parasite Immunol. 35: 409-420.
34. Alturaihi, H., G. S. Hassan, L. Al-Zoobi, S. Salti, Y. Darif, D. Yacoub, S. El Akoum, M. Oudghiri, Y. Merhi, and W. Mourad. 2015. Interaction of CD154 with different receptors and its role in bidirectional signals. Eur. J. Immunol. 45: 592-602.
35. Lu, H. T., D. D. Yang, M. Wysk, E. Gatti, I. Mellman, R. J. Davis, and R. A. Flavell. 1999. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 18: 1845-1857.
36. Zhang, S., and M. H. Kaplan. 2000. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-gamma expression. J. Immunol. 165: 1374-1380.
37. Li, G., J. M. Sanders, M. H. Bevard, Z. Sun, J. W. Chumley, E. V. Galkina, K. Ley, and I. J. Sarembock. 2008. CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury. Am. J. Pathol. 172: 1141-1152.
38. de Oliveira, F. A., C. Vanessa Oliveira Silva, N. P. Damascena, R. O. Passos, M. S. Duthie, J. A. Guderian, A. Bhatia, T. R. de Moura, S. G. Reed, R. P. de Almeida, and A. R. de Jesus. 2013. High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis. BMC Infect. Dis. 13: 331-340.
39. Wright, S. D., J. I. Weitz, A. J. Huang, S. M. Levin, S. C. Silverstein, and J. D. Loike. 1988. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc. Natl. Acad. Sci. USA 85: 7734-7738.
40. Lub, M., Y. van Kooyk, and C. G. Figdor. 1996. Competition between lymphocyte function-associated antigen 1 (CD11a/CD18) and Mac-1 (CD11b/CD18) for binding to intercellular adhesion molecule-1 (CD54). J. Leukoc. Biol. 59: 648-655.
41. Matsuno, R., Y. Aramaki, H. Arima, Y. Adachi, N. Ohno, T. Yadomae, and S. Tsuchiya. 1998. Contribution of CR3 to nitric oxide production from macrophages stimulated with high-dose of LPS. Biochem. Biophys. Res. Commun. 244: 115-119.
42. Talamás-Rohana, P., S. D. Wright, M. R. Lennartz, and D. G. Russell. 1990. Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and LFA-1 family of leukocyte integrins. J. Immunol. 144: 4817-4824.
43. Forget, G., D. J. Gregory, L. A. Whitcombe, and M. Olivier. 2006. Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production. Infect. Immun. 74: 6272-6279.
44. Nandan, D., R. Lo, and N. E. Reiner. 1999. Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect. Immun. 67: 4055-4063.
45. Carter, C. R., J. P. Whitcomb, J. A. Campbell, R. M. Mukbel, and M. A. McDowell. 2009. Complement receptor 3 deficiency influences lesion progression during Leishmania major infection in BALB/c mice. Infect. Immun. 77: 5668-5675.
46. Ferrari, S., S. Giliani, A. Insalaco, A. Al-Ghonaium, A. R. Soresina, M. Loubser, M. A. Avanzini, M. Marconi, R. Badolato, A. G. Ugazio, et al. 2001. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc. Natl. Acad. Sci. USA 98: 12614-12619.